Skip to main content

Affiliate disclosure: We may earn a commission if you buy through links on this site — at no extra cost to you. Thanks!

Best FDA-Approved GLP-1 Providers in 2026

By Weight Loss Provider Guide Editorial Team · Last verified: May 11, 2026

Affiliate disclosure: We may earn a commission when you visit a provider through our links. This does not affect our rankings, recommendations, or editorial independence. Not medical advice.

Best FDA-approved GLP-1 telehealth providers in 2026 — Ro, Sesame, Amazon One Medical, GoodRx, Walgreens, NovoCare, and LillyDirect compared by verified cost and medication access

The best FDA-approved GLP-1 provider for most people in 2026 is Ro. It carries the broadest list of brand-name GLP-1 medications — Wegovy pill, Wegovy pen, Zepbound, the new Zepbound KwikPen, and Foundayo — at the same prices as LillyDirect, NovoCare, and TrumpRx, and it publicly advertises a dedicated insurance concierge that helps file prior-authorization paperwork. Get started for $39 the first month, then as low as $74/month with an annual plan paid upfront. Medication is billed separately. Prescription not guaranteed.

If you want to pick your own doctor and see every brand-name option side-by-side, Sesame Care is the better fit. If you'd rather skip the subscription entirely, Amazon One Medical, NovoCare Pharmacy, and LillyDirect ship the same FDA-approved medication with no membership fee.

One thing most "best of" lists won't tell you upfront: a telehealth provider can't be "FDA-approved." Only medications are FDA-approved. What you're actually shopping for is a provider that helps you access an FDA-approved drug through a licensed clinician — and a lot of the loudest programs out there mostly push compounded GLP-1s, which are a different product category entirely. We separate the two below.

Check Ro coverage and eligibility →

Best fit if you want FDA-approved options plus help with insurance and prior authorization. Medication billed separately. Prescription not guaranteed.

What are the best FDA-approved GLP-1 providers right now?

Quick answer

The best FDA-approved GLP-1 provider depends on three things: whether you have insurance, which medication you want, and how much support you need. Ro is the best overall pick because it carries the full brand-name menu and helps with insurance and prior authorization. Sesame Care wins for medication breadth and clinician choice. Amazon One Medical, NovoCare, and LillyDirect win on raw cash-pay price if you already have a prescriber or want no subscription.
Your situationBest first clickWhy
I have commercial insurance — help me get it coveredRoFree GLP-1 Coverage Checker; insurance concierge helps file prior authorization
I want to pick my own doctor and see the broadest brand menuSesame CareWegovy pill, Wegovy pen, Zepbound (vial, KwikPen, pen), Foundayo, Saxenda, plus diabetes brands when clinically appropriate
I want transparent pricing with a familiar retailerAmazon One MedicalWegovy and Foundayo oral options from $149/month; injectables from $299/month; ships to all 50 states; no One Medical membership required to start
I want the lowest platform fee, cash-payGoodRx Care Direct$39/month care fee; Foundayo and Wegovy pill from $149/month
I don't want any subscription at allWalgreens Weight Management$49/visit, no membership; FDA-approved meds start at $149/month
I want coaching and lifestyle supportWeightWatchers Clinic (Med+)Insurance coordination + behavior-change tools; $25 first month with 12-month plan, renews at $74/month
I'm female-coded and want a familiar brandHersFull Wegovy menu via Novo Nordisk; Zepbound/Foundayo prescriptions can be sent to LillyDirect Pharmacy
I'm male-coded and want a familiar brandHimsFull Wegovy menu via Novo Nordisk; Zepbound/Foundayo prescriptions can be sent to LillyDirect Pharmacy
I already have a prescriber — just want the cheapestNovoCare Pharmacy (Wegovy) or LillyDirect (Zepbound, Foundayo)Direct from the maker; no membership fee
I'm on Medicare Part D or MA-PDWait for the Medicare GLP-1 Bridge (July 1, 2026)$50 fixed cost-sharing for Foundayo, Wegovy tablets, Wegovy injection, and Zepbound KwikPen — if you qualify
I'm open to compounded for a lower priceThis isn't the right pageDifferent category, different tradeoffs — see Best GLP-1 Online Programs
See if Ro is the right fit for you →

Best if your top concern is insurance, prior authorization, or choosing the right medication.

“FDA-approved” — a quick word on language

Quick answer

Telehealth providers are not “FDA-approved.” Medications are. The FDA approves drugs — Wegovy, Zepbound, Foundayo, and Saxenda (and its generic, liraglutide) are FDA-approved for chronic weight management. A telehealth provider is the place where a licensed clinician can prescribe one of those drugs. So when this guide says “FDA-approved GLP-1 providers,” we mean providers that publicly advertise access to FDA-approved GLP-1 medications when a clinician decides it's appropriate for you.

Why does this matter? Because a lot of online programs lead with language like “FDA-registered pharmacy” or “licensed in 50 states,” and then quietly ship you a compounded GLP-1 — a custom-compounded product made by a compounding pharmacy. Compounded semaglutide and tirzepatide are not FDA-approved as finished drugs. The FDA has issued warning letters about unapproved GLP-1 products and the specific risks of dosing errors, salt-form substitutions, and contamination tied to some compounded products.

If you're open to compounded options

Compounded options come with lower cost and different tradeoffs, with more regulatory uncertainty. See Best GLP-1 Online Programs.

The FDA-approved GLP-1 weight-loss medications you can actually get in 2026

Quick answer

The FDA-approved GLP-1 or GLP-1/GIP weight-loss options in 2026 are Wegovy (injection and pill), Zepbound (pen, KwikPen, and vial — Zepbound is a dual GIP/GLP-1 receptor agonist), Foundayo (orforglipron, approved April 1, 2026), and Saxenda (plus its generic, liraglutide injection). Tirzepatide (Zepbound) produces the most weight loss in clinical trials at about 22.5% on the highest dose. Semaglutide (Wegovy) has the deepest cardiovascular outcomes data. Foundayo is the first GLP-1 pill that can be taken at any time of day.
MedicationActive ingredientMakerFormatTrial weight lossApproval status
Wegovy injectionSemaglutideNovo NordiskWeekly pen (0.25–2.4 mg, plus 7.2 mg HD added March 2026)~15% at 2.4 mg (STEP-1); ~19% at 7.2 mg HDFDA-approved for chronic weight management; also approved to reduce risk of heart attack and stroke in eligible adults with established CVD
Wegovy pillOral semaglutideNovo NordiskDaily tablet (1.5, 4, 9, 25 mg)~14% at 25 mg (OASIS)FDA-approved December 2025 — first FDA-approved GLP-1 weight-loss pill
Wegovy HD 7.2 mgSemaglutideNovo NordiskWeekly injection at higher dose~19% in clinical trialFDA-approved March 2026 under the Commissioner's National Priority Voucher pilot
Zepbound (pen / KwikPen)Tirzepatide (dual GIP/GLP-1)Eli LillyWeekly injection (2.5–15 mg)~22.5% at 15 mg (SURMOUNT-1)FDA-approved for chronic weight management; also approved for moderate-to-severe obstructive sleep apnea
Zepbound (single-dose vial)TirzepatideEli LillyWeekly injection from a vial via LillyDirectSame as penSame FDA approval; sold as a cash-pay format
FoundayoOrforglipronEli LillyDaily pill (0.8–17.2 mg)~12.4% at 17.2 mg (ATTAIN-1)FDA-approved April 1, 2026 — the only GLP-1 pill that can be taken any time of day, with or without food or water
Saxenda / generic liraglutideLiraglutideNovo Nordisk / Teva (generic)Daily injection~5–10%FDA-approved for chronic weight management; first generic GLP-1 for weight loss launched by Teva August 2025

Ozempic and Mounjaro are not FDA-approved for weight loss. Ozempic is the diabetes brand of semaglutide. Mounjaro is the diabetes brand of tirzepatide. A clinician can prescribe either off-label for weight management when clinically appropriate — but if you don't have type 2 diabetes, the FDA-approved-for-weight-loss option is Wegovy (semaglutide) or Zepbound (tirzepatide).

Wegovy pill is not the same as compounded oral semaglutide. Wegovy pill is a specific FDA-approved 25 mg tablet from Novo Nordisk with a special absorption technology. Compounded "oral semaglutide" drops or troches are a different product and are not FDA-approved.

Foundayo is brand-new. It received FDA approval April 1, 2026 under the Commissioner's National Priority Voucher pilot — the fastest approval of a new molecule since 2002. Self-pay starts at $149/month for the lowest dose.

Real all-in monthly cost — every FDA-approved GLP-1 by provider (verified May 2026)

Quick answer

The cheapest FDA-approved GLP-1 path in May 2026 starts at $149/month — that's the Wegovy pill at the lowest dose through NovoCare, Foundayo at the starter dose through LillyDirect or Amazon Pharmacy, or the lowest-dose self-pay paths through GoodRx and Walgreens. Brand-name Zepbound runs $299–$449/month direct from Eli Lilly with the manufacturer offer.

What we actually verified

Between May 4 and May 10, 2026, we pulled current pricing directly from each provider's public pricing page, manufacturer program pages, and CMS documents. We did not verify medication potency, individual outcomes, or any non-public business operations. State availability, final clinical eligibility, exact insurance approval, and pharmacy inventory cannot be confirmed before you start an intake. We re-check this page monthly.
Access pathPlatform feeWegovy pillWegovy injectionZepboundFoundayoInsurance / PA support
Ro Body ★$39 first month, then $149/mo; as low as $74/mo with annual prepayMatches NovoCare ($149–$299 by dose); Prepay & Save saves $50/mo on Wegovy pillMatches NovoCare ($199 intro × 2 mo → $349; HD 7.2 mg $399); Prepay & Save saves $100/mo on Wegovy penKwikPen $299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg) with manufacturer offer; pen via insurance with concierge$149 first month, then $199–$299/mo thereafterInsurance concierge files prior auth; free GLP-1 Coverage Checker; FEHB only for government plans
Sesame Care$99/mo monthly, or as low as $59/mo on annual plan$149+/mo by dose$199/mo intro × 2 mo → $349/mo (matches NovoCare)KwikPen dose-based: $299, $398, $499, $698; vial from $299/mo via LillyDirect$149–$349/mo by doseProvider can assist with PA; insurance accepted for eligible meds; Costco members get 10% off services
Amazon One Medical / Amazon PharmacyNo One Medical membership required to startWegovy pill from $149/moWegovy injection from $299/moZepbound from $299/moFoundayo from $149/moTransparent pharmacy pricing; ships all 50 states
Hims & Hers$39 first month, renews at $149/moWegovy pill 1.5/4/9/25 mg from $149/mo (Novo Nordisk access)Wegovy injection 0.25–2.4 mg from $149/mo; 7.2 mg HD availableAffiliated providers can send prescriptions to LillyDirect PharmacyAffiliated providers can send prescriptions to LillyDirect PharmacySelf-pay focused — verify insurance handling per state at checkout
GoodRx Care Direct$39/mo care feeFrom $149/moFrom $199/moFrom $299/moFrom $149/moNot insurance — cash-pay route
Walgreens Weight Management$49 per visit, no subscriptionFrom $149/moFrom $199/moKwikPen dose-based: $299, $399, $449 with manufacturer offerFrom $149/mo (starter); $199–$299/mo with offer at higher dosesDoes not currently handle insurance or prior authorization
WeightWatchers Clinic (Med+)$25 first month with 12-month plan, renews at $74/moAvailable when clinically appropriateAvailable when clinically appropriateAvailable when clinically appropriateNow listed on WW Med+Insurance coordinator can help with coverage and PA
PlushCareVisit / membership model — verify current ratesAvailable when clinically appropriateAvailable when clinically appropriateAvailable when clinically appropriateVerify at intakeCare team can help with PA
NovoCare Pharmacy (Novo Nordisk direct)$0 — no membership$149/mo for 1.5 mg and 4 mg (4 mg offer through Aug 31, 2026, then $199); $299/mo for 9 and 25 mg$199/mo intro × 2 mo for new patients on 0.25/0.5 mg (through June 30, 2026); $349/mo standard; $399/mo for 7.2 mg HDn/a (Novo doesn't make Zepbound)n/an/a — direct self-pay only
LillyDirect (Eli Lilly direct)$0 — no membershipn/an/aVial: $299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg). KwikPen: $449/mo for 7.5–15 mg with offer; higher if refill rules missed ($499 or $699)$149/mo starter dose; $349/mo at top dose regular price; $299/mo purchase offer for 14.5 mg and 17.2 mg when refill rules are metn/a — direct self-pay only

★ = WPG affiliate. Sources: Ro pricing page; Sesame Care medication pages; Amazon News GLP-1 announcement; Hims & Hers investor announcements (March 2026); GoodRx Care Direct; Walgreens Weight Management; WW Med+; PlushCare; NovoCare Wegovy Price Guide PDF; LillyDirect Zepbound Self-Pay Journey Program; FDA Foundayo approval.

What we could not verify before checkout

  • Final clinical eligibility — a clinician decides at intake
  • Exact insurance approval — depends on your plan and PBM
  • State-by-state clinician availability — changes by month
  • Pharmacy inventory at any given moment
  • Whether a limited-time promotional offer is still live when you click
  • Exact Hims/Hers checkout prices by dose (no public price guide like NovoCare)
  • Cancellation and refund terms after medication ships (varies by provider, plan, and order status — confirm at intake)
Run Ro's free GLP-1 Coverage Checker →

See what your insurance covers before you assume you have to pay cash. Takes about 2 minutes.

Ro Body — best overall for FDA-approved GLP-1 care

Quick answer

Ro Body is the best FDA-approved GLP-1 provider for most people in 2026. It carries the full brand-name weight-loss menu — Wegovy pill, Wegovy pen (including 7.2 mg HD), Zepbound pen, Zepbound KwikPen, and Foundayo — at the same prices as NovoCare, LillyDirect, and TrumpRx. Membership is $39 the first month, then $149/month, or as low as $74/month with an annual plan paid upfront. Medication is billed separately. Ro publicly advertises a dedicated insurance concierge that helps with prior-authorization paperwork.

What Ro actually does

  • Carries the full FDA-approved menu. Wegovy pill. Wegovy pen. Zepbound pen. Zepbound KwikPen. Foundayo. Plus Ozempic and Mounjaro for clinically appropriate cases.
  • Matches manufacturer cash pricing. Ro's medication prices match LillyDirect, NovoCare, and TrumpRx. You don't pay a telehealth markup on the drug itself.
  • Prepay & Save. With an annual plan, Ro says you can save $50/month on the Wegovy pill, $100/month on the Wegovy pen, and up to $150/month on the highest Wegovy pen dose — plus the membership drops to as low as $74/month.
  • Free GLP-1 Insurance Coverage Checker. Run it before you commit to anything. Tells you whether your specific plan is likely to cover Wegovy or Zepbound. No payment, no signup.
  • Insurance concierge. Helps file prior authorization and manage the back-and-forth with your insurer.
  • Ongoing clinician access. Messaging, dose-titration support, side-effect management.

Ro's government insurance limit

Ro says it cannot coordinate GLP-1 coverage for government insurance plans except FEHB (the Federal Employees Health Benefits program). If you're on Medicare, Medicaid, Tricare, or VA coverage, Ro can still serve you on a self-pay basis, but the concierge won't be working your government plan. See the Medicare GLP-1 Bridge section below for the Medicare path starting July 1, 2026.

Ro is best for

  • People with commercial insurance who need help getting it to pay
  • People deciding between multiple brand-name options (Wegovy vs. Zepbound vs. Foundayo)
  • People who want one platform handling everything instead of stitching together a prescriber, a pharmacy, and a prior-auth appeal

The honest tradeoff

What most 'best of' pages won't tell you about Ro

Ro is not the cheapest path if you're paying cash and don't need insurance support. If you already have a prescriber, NovoCare (for Wegovy) or LillyDirect (for Zepbound and Foundayo) will give you the same medication at the same price — without the membership fee. Amazon Pharmacy also offers Wegovy and Foundayo from $149/month with no membership required. And if your priority is the lowest platform fee on a cash-pay route, GoodRx Care Direct at $39/month or Walgreens at $49/visit will beat Ro on raw cost.

But here's why Ro still ranks first: most people searching for FDA-approved GLP-1s don't just want the drug. They want help — help figuring out what their insurance covers, help filing prior auth, help choosing between five different medications, help when side effects kick in. That help is the entire reason Ro charges a membership fee. It's worth it if your real problem isn't price, it's friction.

If price is your only issue and you don't need any of that help, scroll down to When to skip telehealth and go direct. We mean it.

What Ro members say

"I was thrilled to not have to fight for my coverage."
"Nothing came close..."
"This has changed my life in so many ways."

— Ro members were paid for these testimonials per Ro's disclosure. Individual results vary and are not typical.

Ro pricing, one more time, in plain English

MedicationMonth 1 priceOngoing priceWith Prepay & Save (annual)
Wegovy pill (1.5 mg, 4 mg)$149/mo$149/mo$99/mo (save $50)
Wegovy pill (9 mg, 25 mg)$299/mo$299/mo$249/mo (save $50)
Wegovy pen (0.25–2.4 mg)$199/mo intro × 2 mo$349/mo$249/mo (save $100)
Wegovy pen HD 7.2 mg$399/mo$399/mo$249/mo (save $150)
Zepbound KwikPen (2.5 mg)$299/mo$299/moNot currently in Prepay offer
Zepbound KwikPen (5 mg)$399/mo$399/moNot currently in Prepay offer
Zepbound KwikPen (7.5–15 mg)$449/mo$449/moNot currently in Prepay offer
Foundayo (starter dose)$149/mo$199–$299/moVerify at intake
Ro platform fee$39 (month 1)$149/moAs low as $74/mo on annual plan

Source: Ro pricing page (ro.co/weight-loss/pricing), verified May 2026. Prices subject to change. Medication billed separately from platform fee. Prescription not guaranteed.

Get started with Ro — $39 the first month →

Ro vs Sesame Care — which is better for FDA-approved GLP-1s?

Quick answer

Ro wins if you have commercial insurance and want help getting it to cover Wegovy or Zepbound. Sesame Care wins if you want to pick your own doctor, see the broadest brand-name menu, or are a Costco member. Both carry Wegovy pill, Wegovy injection, Zepbound, and Foundayo. The deciding factor is how much you need an insurance concierge vs. how much you value clinician choice.
FactorRoSesame Care
Monthly fee$39 first / $149 ongoing / $74 with annual$99/mo, or $59/mo with annual
Choose your clinician?No (assigned)Yes — browse profiles and reviews
Insurance handlingConcierge files prior auth (commercial plans + FEHB only)Provider can assist with PA; insurance accepted for eligible meds
Medication menuWegovy pill, Wegovy pen (incl. 7.2 mg HD), Zepbound pen, Zepbound KwikPen, FoundayoWegovy pill, Wegovy pen, Zepbound pen + vial + KwikPen, Foundayo, Saxenda, plus diabetes brands when clinically appropriate
LabsAvailable; verify at intakeQuest labs included in most states; some excluded
Costco discountNoYes — 10% off services, $29 virtual visits
Government insuranceSelf-pay only outside FEHBVerify your plan at intake
Best forInsurance + PA help, one-stop conciergeClinician choice, transparent self-pay, Costco members

If you're stuck between them and your plan is commercial, start with Ro's free Coverage Checker — it costs nothing and tells you whether your plan will cover the medication. If it won't, Sesame's lower annual rate ($59/month) makes it the cheaper place to land.

Sesame Care — best for medication breadth and choosing your own doctor

Quick answer

Sesame Care has one of the broadest brand-name medication menus in this guide — Wegovy pill, Wegovy injection, Zepbound pen, Zepbound vial, Zepbound KwikPen, Foundayo, Saxenda, plus diabetes brands like Ozempic and Mounjaro when clinically appropriate. Subscription is $99/month, or as low as $59/month with an annual plan. The biggest difference: you browse provider profiles, read patient reviews, and pick the clinician you want. Costco members get 10% off services.

What Sesame actually does

  • One of the broadest brand-name menus. Includes FDA-approved weight-loss options (Wegovy, Zepbound, Foundayo, Saxenda) plus diabetes brands (Ozempic, Mounjaro) when clinically appropriate.
  • Pick your own doctor. Browse profiles, read reviews, choose. No other telehealth platform on this list lets you do that.
  • Insurance accepted for eligible medications.
  • Labs included through Quest in most states (excluded states listed on Sesame's site).
  • Costco partnership. $29 virtual visits and 10% off Sesame services for Costco members.
  • Zepbound KwikPen at Sesame: dose-based pricing — $299, $398, $499, $698 depending on dose.

Sesame is best for

  • People who want to compare clinicians before committing
  • People with no insurance who want transparent self-pay medication prices
  • Costco members
  • People who want the broadest brand-name menu in one place

The honest tradeoff

Sesame is more of a marketplace than a managed program. You drive the relationship with whichever doctor you pick. If you want a high-touch concierge experience where one team manages your whole journey, Ro is the better fit. If you'd rather control the experience yourself, Sesame is the better fit.

Browse Sesame doctors and current pricing →

Best if provider choice matters more than a one-stop concierge program. Membership and medication billed separately.

Which FDA-approved GLP-1 provider is cheapest without insurance?

Quick answer

For pure platform fee, GoodRx Care Direct at $39/month is the cheapest subscription, and Walgreens at $49/visit is the cheapest no-subscription option. For the cheapest total cost on the medication itself, NovoCare Pharmacy (for Wegovy) and LillyDirect (for Zepbound and Foundayo) skip the membership entirely and ship direct from the manufacturer. Amazon Pharmacy matches manufacturer pricing on Wegovy and Foundayo oral options from $149/month and injectables from $299/month with no membership required.
Cash-pay optionPlatform feeLowest medication priceBest for
NovoCare Pharmacy$0Wegovy pill $149/mo (1.5 mg, 4 mg)Already have a prescription for Wegovy
LillyDirect$0Foundayo $149/mo (starter); Zepbound vial $299/mo (2.5 mg)Already have a prescription for Zepbound or Foundayo
Amazon One Medical / Amazon PharmacyNo One Medical membership requiredWegovy pill, Foundayo from $149/mo; injectables from $299/moWant transparent pricing + 50-state shipping
GoodRx Care Direct$39/mo care feeFoundayo, Wegovy pill from $149/moWant simplest low-fee subscription
Walgreens Weight Management$49/visit, no subscriptionFDA-approved GLP-1s from $149/moWant no subscription, pay-as-you-go
Sesame Care (annual)$59/mo on annual planWegovy pill from $149/mo, Zepbound from $299/moWant clinician choice + lower annual rate
Ro Body (annual)$74/mo on annual planMatches manufacturer pricing + Prepay & SaveWant insurance concierge even if paying cash

The big question: do you already have a prescriber willing to write you a GLP-1 prescription? If yes, NovoCare, LillyDirect, or Amazon will be cheapest. If no, you need a telehealth platform to get the prescription written — and the lowest platform fee that includes a clinician is GoodRx Care Direct at $39/month or Walgreens at $49 per visit.

Hims and Hers — best for mainstream brand familiarity

What changed at Hims and Hers in 2026

Hims & Hers announced in March 2026 (investor announcements March 9 and March 26, 2026) that affiliated providers can now route Zepbound and Foundayo prescriptions directly to LillyDirect Pharmacy. This means Hims and Hers readers can now access the full Wegovy menu and have Zepbound/Foundayo prescriptions sent to LillyDirect for fulfillment.

Hims / Hers is best for

  • People who trust the Hims or Hers brand and want a full Wegovy menu (pill, pen, HD)
  • People who want Zepbound or Foundayo routed to LillyDirect for fulfillment
  • People who prefer a polished, app-first experience

Hims / Hers pricing

MedicationPriceNotes
Platform fee (Hims or Hers)$39 first month, renews at $149/moNot all 50 states
Wegovy pill (1.5/4/9/25 mg)From $149/moNovo Nordisk access; dose-based
Wegovy injection (0.25–2.4 mg)From $149/moNovo Nordisk access; 7.2 mg HD available
ZepboundPrescriptions routed to LillyDirect PharmacySource: Hims & Hers March 2026 investor announcement
FoundayoPrescriptions routed to LillyDirect PharmacySource: Hims & Hers March 2026 investor announcement

The honest tradeoff

  • Hims & Hers does not publish a complete public price guide the way NovoCare does — exact per-dose prices require going through checkout
  • Not available in all 50 states; verify availability at checkout
  • Self-pay focused — if your real need is insurance help, Ro is the better fit
  • Polished app experience; familiar brand for readers who have used Hims or Hers for other health products
  • LillyDirect prescription routing is a genuine upgrade for Zepbound and Foundayo access

Amazon One Medical, GoodRx Care Direct, Walgreens, WeightWatchers Clinic, and PlushCare — when these win

We don't run affiliate links to all of these providers. We're including them because they're real options that legitimately fit certain readers, and your search deserves the full picture — not just the providers that pay us.

Amazon One Medical / Amazon Pharmacy — best transparent-pricing retailer route

  • No One Medical membership required to start GLP-1 care
  • Wegovy pill and Foundayo from $149/month; injectables (Wegovy injection, Zepbound) from $299/month
  • Ships to all 50 states through Amazon Pharmacy
  • Transparent pricing before you commit — no paywall to see costs
  • Best for readers who want a familiar retailer brand, nationwide shipping, and clear pricing without a subscription

GoodRx Care Direct — best low-fee cash-pay route

  • $39/month care fee — the lowest subscription fee among GLP-1 telehealth platforms
  • Wegovy pill, Foundayo from $149/month; Wegovy injection from $199/month; Zepbound from $299/month
  • Not available in Alabama or Louisiana
  • GoodRx Care Direct is not insurance — this is a cash-pay platform
  • Best for people who want a simple, low-fee, FDA-approved-only path and don't need an insurance concierge

Walgreens Weight Management — best no-subscription option

  • $49 per visit. No subscription. No membership.
  • FDA-approved GLP-1s — Wegovy, Zepbound, Foundayo, Saxenda — starting at $149/month
  • Zepbound KwikPen pricing is dose-based: $299, $399, $449 with manufacturer offer (higher if refill-timing rules are missed)
  • Does not currently handle insurance or prior authorization — if your real problem is coverage, this isn't the right fit
  • Labs required for refills
  • Best for people who want a recognizable pharmacy brand and pay-as-you-go pricing

WeightWatchers Clinic (Med+) — best coaching-supported route

  • Med+ starts at $25 first month with a 12-month plan, then $74/month
  • Medication separate
  • Clinicians prescribe FDA-approved options including Wegovy, Saxenda, Zepbound, and now Foundayo when clinically appropriate
  • Insurance coordinator helps with coverage, prior authorization, and refills
  • Includes the WeightWatchers behavior-change program — this is the differentiator
  • Best for people who want lifestyle support alongside medication, not just a prescription

PlushCare — best traditional online doctor route

  • Visit and membership pricing — verify current rates on PlushCare's site
  • Lists FDA-approved weight-loss GLP-1s including Wegovy, Saxenda, and Zepbound
  • Care team can help with prior authorization
  • Best for people who want a primary-care-style online doctor visit, not a GLP-1-specific shopping experience

When to skip telehealth and go direct to NovoCare or LillyDirect

Quick answer

If you already have a prescriber, the cheapest path to FDA-approved GLP-1 medication is to skip the telehealth subscription entirely. NovoCare Pharmacy ships Wegovy direct from Novo Nordisk for $149–$499/month depending on formulation and dose. LillyDirect ships Zepbound and Foundayo direct from Eli Lilly for $149–$449/month. No membership fee. No subscription. You bring the prescription, they ship the medication.

NovoCare Pharmacy — Wegovy direct from Novo Nordisk

  • Wegovy injection: $199/month first 2 months for new patients on the 0.25 mg or 0.5 mg dose (offer runs through June 30, 2026), then $349/month standard for 0.25–2.4 mg, and $399/month for the 7.2 mg HD dose.
  • Wegovy pill: $149/month for the 1.5 mg and 4 mg doses (4 mg intro pricing through August 31, 2026, then $199/month). $299/month for 9 mg and 25 mg doses.
  • HSA/FSA eligible
  • No membership fee
  • You bring the prescription from any U.S.-licensed prescriber

LillyDirect — Zepbound and Foundayo direct from Eli Lilly

  • Zepbound single-dose vial: $299/month (2.5 mg), $399/month (5 mg), $449/month (7.5, 10, 12.5, 15 mg)
  • Zepbound KwikPen: $449/month for 7.5–15 mg doses with the manufacturer offer; if refill-timing rules are missed, higher-dose refills can rise to $499 or $699
  • Foundayo: $149/month for the starter dose; up to $349/month at the top doses (regular price). A purchase offer of $299/month is available for the 14.5 mg and 17.2 mg doses when refill-timing rules are met.
  • HSA/FSA eligible
  • No membership fee. You bring the prescription.

TrumpRx — government-affiliated discount portal

TrumpRx is an alternate pricing channel that links to manufacturer direct-to-consumer discount programs. Wegovy injectables run $199 first 2 months to $399/month, Zepbound KwikPen up to $699/month, Wegovy pill up to $299/month, and Foundayo up to $349/month at the highest doses.

The honest tradeoff

Going direct to NovoCare or LillyDirect is unbeatable on raw cost if you already have a prescriber. You give up: dose-titration support over time, side-effect management chat, prior-auth handling, easy switching between medications, and a single platform for refills. For most readers, that scaffolding is worth a small monthly fee. But if you've been on a GLP-1 before, manufacturer-direct is often the right call.

Which online GLP-1 provider helps with prior authorization?

Quick answer

Ro has the most explicit prior-authorization concierge program and includes a free GLP-1 Coverage Checker. Sesame Care, PlushCare, and WeightWatchers Clinic also offer insurance and PA support through their care teams. Walgreens does not currently handle insurance or prior authorization. GoodRx Care Direct is a cash-pay platform, not an insurance route.

The PBM landscape, plain English

Your insurance card has a logo (Aetna, Cigna, UnitedHealthcare, Blue Cross). The pharmacy benefit manager — PBM — is the company actually deciding which GLP-1s your plan covers.

  • CVS Caremark removed Zepbound from its standard formulary effective July 1, 2025, while keeping Wegovy and Saxenda as preferred options. Employer and custom formularies can differ.
  • OptumRx (UnitedHealthcare) generally requires prior authorization for GLP-1 weight-loss medications. Specific criteria vary by plan.
  • Cigna (Express Scripts) generally treats GLP-1s under a class prior-authorization with quantity limits.

What insurers usually want for prior authorization

  • BMI ≥30, or ≥27 with a qualifying weight-related condition
  • Documentation of previous weight-loss attempts (diet, exercise, prior medications)
  • Sometimes step therapy — try one medication first before approving another
  • Diagnosis codes for any qualifying conditions

The manufacturer savings cards

NovoCare Savings Card (Wegovy): Eligible commercially insured patients can pay as little as $0–$25/month. Not valid for Medicare, Medicaid, or Tricare.
Zepbound Savings Card: Eligible patients with commercial insurance can pay as little as $25/month.
Foundayo Savings Card: Commercially insured patients can pay as little as $25/month with the Foundayo savings card.

Why Ro's concierge matters here

Ro's insurance concierge runs the Coverage Checker before you pay anything, helps file the prior authorization with supporting documentation, and helps manage appeals. The catch: Ro cannot coordinate GLP-1 coverage for government insurance plans except FEHB. If you're on Medicare, Medicaid, Tricare, or VA, see the Medicare Bridge section below for your path.

If your plan flatly excludes weight-loss drugs (no GLP-1 will ever be covered for weight management), no concierge can fix that. Your real options become self-pay or an appeal under a different indication — for example, cardiovascular risk for Wegovy or obstructive sleep apnea for Zepbound when clinically appropriate.

Run Ro's free GLP-1 Coverage Checker →

Free. Takes about 2 minutes. Tells you what your plan covers before you commit.

Medicare GLP-1 Bridge — $50/month starting July 1, 2026

Quick answer

Eligible Medicare Part D and Medicare Advantage prescription drug (MA-PD) beneficiaries can access Foundayo (all formulations), Wegovy tablets, Wegovy injection, and Zepbound KwikPen through the Medicare GLP-1 Bridge starting July 1, 2026, with a $50 fixed cost-sharing amount. The Bridge runs through December 31, 2027. Eligibility is tiered by BMI and qualifying conditions — it is not simply “BMI ≥27 with any qualifying condition.” (Source: CMS Medicare GLP-1 Bridge program page.)

What's covered through the Bridge

  • Foundayo — all formulations
  • Wegovy — tablets and injection
  • Zepbound — KwikPen formulation only

What's NOT covered

  • Zepbound single-dose vials and single-dose pens — explicitly excluded
  • Ozempic and Mounjaro — continue under standard Part D for type 2 diabetes, not the Bridge
  • Compounded semaglutide or tirzepatide

CMS Bridge eligibility — the actual criteria

CMS lists three eligibility paths. You must meet one of these:

  1. BMI ≥35, OR
  2. BMI ≥30 with one of the following: heart failure with preserved ejection fraction (HFpEF), uncontrolled hypertension, or chronic kidney disease (CKD) stage 3a or higher, OR
  3. BMI ≥27 with one of the following: prediabetes, previous myocardial infarction (heart attack), previous stroke, or symptomatic peripheral artery disease

You must also be enrolled in Medicare Part D or an MA-PD plan, and your prescriber must submit a prior authorization to the CMS central processor confirming the clinical criteria were met when GLP-1 therapy started.

The catches

  • The Bridge operates outside the standard Part D benefit
  • The $50 fixed cost-sharing does not count toward True Out-of-Pocket (TrOOP) accumulation or your Part D deductible
  • The low-income subsidy (Extra Help) does not apply to Bridge drugs
  • CMS is extending the GLP-1 Bridge through December 31, 2027

If you're currently on Zepbound vials

The Bridge covers the KwikPen formulation of Zepbound only. If you're currently buying Zepbound vials through LillyDirect, talk to your prescriber about switching to the KwikPen before July 1 if you want the $50 Bridge cost-sharing — same drug, same active ingredient, just the device that qualifies.

Source: Centers for Medicare & Medicaid Services (CMS), Medicare GLP-1 Bridge program page.

Who shouldn't use this ranking

We'd rather lose you to the right page than keep you here and waste your time.

  • If you want compounded GLP-1s for the lower price — this is the wrong page. See Best GLP-1 Online Programs for an honest comparison.
  • If you have type 2 diabetes and want a diabetes-first ranking — see Best GLP-1 for Diabetes.
  • If you're under 18, pregnant, or planning pregnancy — this is an adult telehealth comparison and isn't the right route for you.
  • If you have a personal or family history of medullary thyroid cancer or MEN2 — GLP-1s carry a boxed warning. This is a hard contraindication. Talk to your doctor first.
  • If you're in a medical emergency — call 911 or your doctor. This is a comparison page, not urgent care.

Our methodology — how we ranked these providers

Quick answer

We ranked providers on how well they solve the actual search intent — access to FDA-approved GLP-1 medications — not on which one pays us the highest commission. We separated FDA-approved medications from compounded products, weighted insurance and prior-authorization support, and penalized any provider that hid pricing behind a paywall or pushed compounded as a default.

Scoring framework

CategoryWeight
FDA-approved medication menu and clarity25%
True-cost transparency (verifiable pricing, including ongoing cost after intro pricing)20%
Insurance and prior-authorization support20%
Match to specific reader segment (insurance-sensitive, cash-pay, no-subscription, etc.)15%
Practical friction (state availability, lab requirements, refill policies, cancellation terms)10%
Trust and proof signals (legitimate testimonials, disclosure, regulatory standing)10%

What hurt a provider's ranking

  • Compounded-first positioning (this page is FDA-approved-only)
  • Pricing hidden until checkout
  • No prior-authorization help for insurance-sensitive readers
  • Promotional pricing without clearly stated renewal cost
  • Vague or missing cancellation terms

What didn't count

  • Star ratings without verifiable user reviews
  • Unsourced testimonials
  • “Clinical superiority” claims that aren't backed by trial data
  • Affiliate commission rate

Brand identity statement

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We earn affiliate commissions when readers click through to some providers — including Ro, Sesame Care, Hims, and Hers. We disclose that clearly. Manufacturer-direct paths (NovoCare, LillyDirect, TrumpRx), Amazon One Medical, GoodRx Care Direct, Walgreens Weight Management, WeightWatchers Clinic, and PlushCare are included because they're real options for real readers, not because we earn from them. Our editorial priority is reader fit and verified evidence — not commission.

Frequently asked questions

Ro is the best FDA-approved GLP-1 provider for most people because it carries the full brand-name menu (Wegovy, Zepbound, Foundayo) at the same prices as the manufacturers, plus an insurance concierge that helps with prior-authorization paperwork. Sesame Care is the strongest runner-up for medication breadth and clinician choice. Amazon One Medical, GoodRx Care Direct, and Walgreens are better for low-fee or no-subscription cash-pay routes.

In May 2026, the FDA-approved GLP-1 (or GLP-1/GIP) medications for chronic weight management are Wegovy (injection and pill), Zepbound (pen, KwikPen, and single-dose vial — Zepbound is a dual GIP/GLP-1 receptor agonist), Foundayo (orforglipron, approved April 1, 2026), and Saxenda (plus its generic, liraglutide injection). Ozempic and Mounjaro are FDA-approved for type 2 diabetes, not weight loss, but can be prescribed off-label when clinically appropriate.

In May 2026, the lowest verified self-pay prices for FDA-approved GLP-1s start at $149/month — that's the Wegovy pill at the 1.5 mg or 4 mg dose through NovoCare, Foundayo at the starter dose through LillyDirect or Amazon Pharmacy, or the lowest-dose self-pay paths through GoodRx and Walgreens. Wegovy injection runs $199/month for the first two months on the lowest doses (NovoCare intro offer through June 30, 2026), then $349/month. Zepbound runs $299–$449/month through LillyDirect depending on dose and format.

Ro, Sesame Care, Hims, Hers, Amazon One Medical, GoodRx Care Direct, Walgreens Weight Management, WeightWatchers Clinic, PlushCare, and NovoCare Pharmacy directly. Ro is the best choice for most people because it matches NovoCare pricing and adds an insurance concierge. NovoCare Pharmacy is the cheapest if you already have a prescription.

Ro, Sesame Care, Hims, Hers, Amazon One Medical, GoodRx Care Direct, Walgreens Weight Management, or directly through LillyDirect. Zepbound KwikPen is dose-based: $299 for 2.5 mg, $399 for 5 mg, $449 for 7.5–15 mg with the manufacturer offer through LillyDirect or Ro.

Foundayo (orforglipron) was FDA-approved on April 1, 2026 and is available through LillyDirect, Amazon Pharmacy, Ro, Sesame Care, WeightWatchers Clinic, and Walgreens (Hims/Hers can route Foundayo prescriptions to LillyDirect). Self-pay prices range from $149/month at the starter dose to $349/month at the highest dose, with a $299/month purchase offer available at the 14.5 mg and 17.2 mg doses when refill rules are met.

Yes. The FDA approved Foundayo (orforglipron) for chronic weight management on April 1, 2026 under the Commissioner's National Priority Voucher pilot program. It's the first new molecular entity approved under that program and the fastest approval of a new drug since 2002. Foundayo is an oral pill made by Eli Lilly.

Yes. Novo Nordisk announced FDA approval of Wegovy pill (oral semaglutide 25 mg) for chronic weight management in December 2025. It's the first FDA-approved GLP-1 pill for weight loss. It's not the same as compounded "oral semaglutide" products sold by some telehealth platforms.

No. Ozempic is FDA-approved for type 2 diabetes. A clinician can prescribe it off-label for weight management, but the FDA-approved-for-weight-loss version of the same molecule (semaglutide) is Wegovy. If you want an FDA-approved-for-weight-loss option, ask about Wegovy instead.

No. Mounjaro is FDA-approved for type 2 diabetes. Zepbound is the FDA-approved-for-weight-loss version of the same molecule (tirzepatide). If you don't have diabetes and you're seeking weight management, Zepbound is the FDA-approved option.

No. Compounded semaglutide and tirzepatide are custom-compounded products made by compounding pharmacies and are not FDA-approved as finished drugs. The FDA has issued warning letters about unapproved GLP-1 products, dosing errors in some compounded preparations, and salt-form substitutions that aren't the same active ingredient as the approved drug. Compounded products are a different regulatory category from brand-name FDA-approved GLP-1s.

Ro has the most explicit prior-authorization concierge program for commercial plans (and FEHB). Sesame Care, PlushCare, and WeightWatchers Clinic also offer insurance and PA support through their care teams. Walgreens does not currently handle insurance or prior authorization. GoodRx Care Direct is a cash-pay platform, not an insurance route.

For pure platform fee, GoodRx Care Direct at $39/month is the cheapest subscription, and Walgreens at $49/visit is the cheapest no-subscription option. For the cheapest total cost when you already have a prescription, NovoCare Pharmacy (Wegovy), LillyDirect (Zepbound, Foundayo), and Amazon Pharmacy (Wegovy, Foundayo, injectables) skip the membership entirely.

Eligible Medicare Part D and MA-PD beneficiaries can access Foundayo, Wegovy tablets, Wegovy injection, and Zepbound KwikPen at $50 fixed cost-sharing starting July 1, 2026, through the Medicare GLP-1 Bridge demonstration program. The program runs through December 31, 2027. Eligibility is BMI ≥35; OR BMI ≥30 with HFpEF, uncontrolled hypertension, or CKD stage 3a+; OR BMI ≥27 with prediabetes, previous heart attack, previous stroke, or symptomatic peripheral artery disease. Your prescriber must submit a prior authorization to the CMS central processor.

Ro is better if you have commercial insurance and need help with coverage and prior authorization. Sesame is better if you want to choose your own doctor, see the broadest brand-name menu, or are a Costco member. Both carry Wegovy pill, Wegovy injection, Zepbound, and Foundayo. Ro cannot coordinate government insurance except FEHB, so Medicare and Medicaid readers should look elsewhere.

Cancellation terms vary by provider, plan length, and whether medication has shipped. Confirm cancellation and refund terms at intake before you commit to a long-term plan. Don't assume terms are uniform across providers.

Still not sure which path fits your situation?

If you're stuck choosing between insurance, cash-pay, manufacturer-direct, and oral vs. injection, take our free 60-second matching quiz. We'll match you to the provider best suited to your specific situation, with an estimated all-in monthly cost.

Take our free 60-second matching quiz →

Sources, verification, and disclosure

Last verified: . We re-verify pricing and provider policies monthly. Manufacturer pricing pages, FDA approval announcements, and CMS Medicare Bridge details are re-checked at least monthly or whenever a regulatory update occurs.

Primary sources used to build this page:

  • FDA prescribing information for Wegovy, Zepbound, Foundayo, and Saxenda (and DailyMed for current labels)
  • FDA press releases on Foundayo approval (April 1, 2026) and Wegovy HD 7.2 mg approval (March 2026)
  • FDA's communications on concerns with unapproved GLP-1 drugs used for weight loss
  • Novo Nordisk announcement on Wegovy pill FDA approval (December 2025)
  • Teva announcement on FDA approval and launch of generic Saxenda (liraglutide), August 2025
  • NovoCare Wegovy Price Guide (published PDF) and NovoCare Pharmacy program pages
  • LillyDirect Zepbound Self-Pay Journey Program and Foundayo program pages
  • Ro Body pricing page (ro.co/weight-loss/pricing) and weight-loss landing page
  • Sesame Care online weight-loss program page and medication-specific pages
  • Hims & Hers investor announcements (March 9 and March 26, 2026; LillyDirect prescription-routing announcement)
  • Amazon News on Amazon One Medical GLP-1 Management Program with Amazon Pharmacy fulfillment
  • GoodRx Care Direct GLP-1 page
  • Walgreens Weight Management page and Foundayo page
  • WeightWatchers Clinic Med+ and Foundayo pages
  • PlushCare GLP-1 prescription page
  • CMS Medicare GLP-1 Bridge program page
  • AP News reporting on CVS Caremark formulary changes (2025)
  • Published clinical trial data: STEP-1 (NEJM 2021), SURMOUNT-1 (NEJM 2022), SELECT (NEJM 2023), OASIS series, ATTAIN-1

About Weight Loss Provider Guide: Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We may earn a commission when readers click through to certain providers. This does not affect our rankings, recommendations, or editorial independence. We are not a medical practice. Nothing on this page is medical advice. Talk to a licensed clinician before starting or stopping any medication.

By the Weight Loss Provider Guide Editorial Team.